Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, May 9, 2024.
Arbutus Biopharma Corporation (NASDAQ:ABUS)
Bull Market Weakness (+75) - ABUS is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Keep an eye on ABUS as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid ABUS?
MarketClub looks at technical strength and momentum to determine if the timing is right for ABUS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for ABUS
The long-term trend has been UP since Dec 14th, 2023 at 2.210
The intermediate-term trend has been DOWN since May 2nd, 2024 at 2.635
The short-term trend has been UP since May 3rd, 2024 at 2.795
Smart Scan Analysis for ABUS
Based on our trend formula, ABUS is rated as a +75 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 2.8600 | 2.8799 | 2.7900 | 2.8350 | -0.0050 |
| Prev. Close | Volume | Bid | Ask | Time |
| 2.8400 | 118920 | 2024-05-09 11:32:10 |
| Year High | 12.6 | Year High Date | 2018-08-02 |
| Year Low | 4.01 | Year Low Date | 2018-10-15 |
| 52wk High | 3.29 | 52wk High Date | 2024-04-05 |
| 52wk Low | 1.69 | 52wk Low Date | 2023-10-24 |
| Average Volume | 867,322 | Shares Outstanding | 188,717 |
| Market Cap | 103M | Assets | 150,290,000M |
| Liabilities | 35,653,000M | P/E Ratio | -3.08220000 |
| Volatility | 102.46 |